Glycemic control Reduction of body weight Lipid control Medical nutrition therapy Self blood glucose monitoring type 2 diabetes
Conditions
Interventions
We give individualized medical nutritional therapy together with self blood glucose monitoring for this arm.
Both arms are received their own and unchanged diabetic medications.
For safety issue,
both arms may be decrease in diabetic medications,
if feasible with hypoglycemia,We give our usual care to patients with type 2 diabetes.
Both arms are received their own and unchanged diabetic medications.
For safety issue,
if feasible with hypoglycemia
Experimental Behavioral,No Intervention Other
Medical nutritional therapy plus Self blood glucose monitoring,Usual care
Sponsors
Faculty of Medicine, Srinakharinwirot University
Faculty of Medicine,
Srinakharinwirot University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. diagnosis of type 2 diabetes 2. Hemoglobin A1C more than 6.5 % within 3 months before enrollment
Exclusion criteria
Exclusion criteria: 1. Hemoglobin A1C more than 9% within 3 months before enrollment 2. insulin or Glucagon-like peptide-1 agonist users 3. Liver cirrhosis 4. Pregnancy or expected to pregnant within 1 year 5. Receive tube feeding 6. Glomerular filtration rate less than 60 ml/min/1.73m2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin A1C 12 and 24 weeks after start medical nutritional therapy %/ blood test | — |
Secondary
| Measure | Time frame |
|---|---|
| Fasting plasma glucose 12 and 24 weeks after start medical nutritional therapy mg/dL blood test,Body weight 12 and 24 weeks after start medical nutritional therapy Kilograms,Low Density Lipoprotein-cholesterol 12 and 24 weeks after start medical nutritional therapy mg/dL blood test,Triglyceride 12 and 24 weeks after start medical nutritional therapy mg/dL blood test | — |
Countries
Thailand
Contacts
Public ContactKanchana Ngaosuwan
Faculty of Medicine, Srinakharinwirot University
Outcome results
None listed